Default company panoramic image
2a397d9b 6541 4096 9a15 2009b59d26ff

CvergenX, Inc.

CvergenX is a cancer molecular diagnostics services company with a lab developed test that predicts a tumor’s response to radiation therapy.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Tampa, FL, USA
  • Currency USD
  • Founded June 2009
  • Employees 1
  • Website

Company Summary

CvergenX is the first cancer molecular diagnostics company to develop a companion diagnostic for Radiation Therapy (RT). We will operate as an independent laboratory with testing that provides information for the first time that predicts a tumor’s sensitivity to radiation and assists the radiation oncologist in making more informed therapeutic decisions.


  • Default avatar
    Steven Eschrich, Ph D
    Chief Technical Officer

  • Default avatar
    Mary Del Brady
    Chairman & CEO

  • Default avatar
    Javier Torres-Roca, MD
    Chief Medical Officer


  • Default avatar
    John Igoe, JD, Partner - Edwards Angell Palmer & Dodge
    Default avatar
    Anthony Duronio, Partner - Lally & Lally

Previous Investors

  • Default avatar
    Private Investors